PulseAugur
中
实时 22:13:28

Google DeepMind spinoff Isomorphic Labs raises $2.1B for AI drug trials

作者 PulseAugur 编辑部 · [5 个来源] ·

Isomorphic Labs, an AI-driven drug discovery company spun out of Google DeepMind, has secured over $2 billion in a Series B funding round. The substantial investment, led by Thrive Capital, will be used to expand its proprietary drug design engine, IsoDDE, and advance its pipeline of drug candidates toward human clinical trials. The company leverages DeepMind's AlphaFold technology to predict protein structures and design potent, low-side-effect medicines. AI

影响 Accelerates AI's role in drug discovery, potentially leading to faster development of new medicines and treatments.

排序理由 Significant funding round for an AI-driven drug discovery company with plans for human trials.

在 Wired — AI 阅读 →

AI 生成摘要 · Google Gemini · 来自 5 个来源。 我们如何撰写摘要 →

Google DeepMind spinoff Isomorphic Labs raises $2.1B for AI drug trials

报道来源 [5]

  1. 36氪 (36Kr) TIER_1 中文(ZH) ·

    Google's Isomorphic Labs plans to raise over $2 billion in new funding round

    据报道，谷歌DeepMind分拆出来的AI驱动药物研发公司Isomorphic Labs正深入洽谈，计划在新一轮融资中筹集超过20亿美元。知情人士称，曾主导Isomorphic Labs去年首轮融资的风投机构Thrive Capital将牵头本轮新融资，Alphabet也将参与。（界面）

  2. Wired — AI TIER_1 English(EN) · Emily Mullin ·

    AI-Designed Drugs by a DeepMind Spinoff Are Headed to Human Trials

    Isomorphic Labs president Max Jaderberg said at WIRED Health in London that the startup has built a “broad and exciting pipeline of new medicines.”

  3. The Decoder TIER_1 English(EN) · Matthias Bastian ·

    Alphabet's Isomorphic Labs raises $2.1 billion to scale AI drug discovery toward clinical trials

    <p><img alt="" class="attachment-full size-full wp-post-image" height="768" src="https://the-decoder.com/wp-content/uploads/2026/05/iso_labs_logo.png" style="height: auto; margin-bottom: 10px;" width="1376" /></p> <p> Isomorphic Labs, the AI drug research company led by DeepMind …

  4. Forbes — Innovation TIER_1 English(EN) · Amy Feldman, Forbes Staff ·

    Isomorphic Labs’ $2.1 Billion Fundraise Is The Biggest Bet Yet On AI Drug Discovery

    Isomorphic, which formed as an Alphabet company in 2021, has a massive cash horde, but it’s tight-lipped on what drugs it might bring to the clinic.

  5. Mastodon — fosstodon.org TIER_1 English(EN) · [email protected] ·

    DeepMind spinout Isomorphic Labs has raised 2.1 billion USD in Series B funding to build AI-powered drug discovery platforms. The UK AI company, which spun out

    DeepMind spinout Isomorphic Labs has raised 2.1 billion USD in Series B funding to build AI-powered drug discovery platforms. The UK AI company, which spun out from Google DeepMind in 2021, uses AlphaFold protein structure technology to design new medicines. # Tech # Startup # Ne…

    链接 sifted.eu/…/isomorphic-labs-2-1bn

相关实体

相关话题